FX.co ★ Immunome, Inc. Q1 Loss Increases, Misses Estimates

Immunome, Inc. (IMNM) has reported a significant increase in its losses for the first quarter compared to the same period last year, failing to meet Wall Street expectations.

The company’s net loss amounted to $129.51 million, or $2.51 per share, compared to a loss of $4.27 million, or $0.35 per share, in the first quarter of the previous year.

Analysts, as surveyed by Thomson Reuters, had anticipated a loss of $0.69 per share, excluding special items.

Revenue for the quarter decreased by 56.4% to $1.03 million, down from $2.36 million the previous year.

Key financial figures for Immunome, Inc. (GAAP) this quarter are as follows:

- Earnings (Q1): -$129.51 million vs. -$4.27 million last year.

- EPS (Q1): -$2.51 vs. -$0.35 last year.

- Revenue (Q1): $1.03 million vs. $2.36 million last year.